feed,title,long_url,short_url
MedRxiv,Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up,https://medrxiv.org/cgi/content/short/2025.04.09.25325550v1?rss=1,https://da.gd/Grvjle
MedRxiv,Impact of Covid-19 Control Strategies on Health and GDP Growth Outcomes in 193 Sovereign Jurisdictions,https://medrxiv.org/cgi/content/short/2025.04.08.25325452v1?rss=1,https://da.gd/VT7pke
